About this webinar
A new frontier in treating mental health conditions, psychedelic therapy has brought about lasting change for patients and people around the world. Field Trip Health has been facilitating psychedelic-assisted therapy since March 2020 in our Health Centres across North America – and we’re thrilled to publish a whitepaper report outlining the importance of this medicine and preliminary results from the protocol.
Dr. Ben Medrano, MD (Field Trip Medical Director, New York) and Dr. Michael Verbora, MBA MD (Field Trip Medical Director, Toronto) will discuss the paper, present the researched-based evidence of the efficacy of psychedelic therapies, and outline the ongoing clinical work that Field Trip Health is facilitating, using ketamine-assisted therapy to treat treatment-resistant mental health conditions with lasting success.
This session will deliver useful & thought-provoking information catered to care providers, clients, and the psychedelic community at large as we delve into our whitepaper publication. This session will have plenty of opportunity for participants to ask questions of our presenters and have them answered live, so come with your curiosity in hand.
Visit our website to download your copy of the whitepaper now!
Learn more about how Field Trip Health uses evidence-based, legal psychedelic therapies to help you heal depression and feel better.
Share this event